Atypical Fibroxanthoma

specific

An intermediate cutaneous mesenchymal neoplasm of uncertain differentiation, usually affecting the actinic-damaged skin of the elderly. The tumor presents as a single cutaneous nodule which is often ulcerated. Microscopically, it is characterized by the presence of highly atypical cytologic features, pleomorphism and abundant mitotic figures. The vast majority of patients have an excellent prognosis following conservative therapy. Recurrences are infrequent, and metastasis is rare.

68

Centers

73

Active Trials

Cancer Funding

Top Centers for Atypical Fibroxanthoma(68)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.6
2
High-Volume Research Center
71.6
3
High-Volume Research Center
71.6
4
High-Volume Research Center
71.6
5
High-Volume Research Center
71.6
6
NCI Comprehensive
Active Research Program
49.1
7
NCI Comprehensive
Active Research Program
49.1
8
NCI Comprehensive
Active Research Program
49.1
9
NCI Comprehensive
Active Research Program
49.1
10
NCI Comprehensive
Active Research Program
49.1
11
NCI Comprehensive
Active Research Program
49.1
12
NCI Comprehensive
Active Research Program
49.1
13
NCI Comprehensive
Active Research Program
49.1
14
NCI Comprehensive
Active Research Program
49.1
15
NCI Comprehensive
Active Research Program
49.1
16
NCI Comprehensive
Active Research Program
49.1
17
NCI Comprehensive
Active Research Program
49.1
18
NCI Comprehensive
Active Research Program
49.1
19
NCI Comprehensive
Active Research Program
49.1
20
NCI Comprehensive
Active Research Program
49.1
21
NCI Comprehensive
Active Research Program
49.1
2249.1
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.1
24
NCI Comprehensive
Active Research Program
49.1
25
NCI Comprehensive
Active Research Program
49.1
26
NCI Comprehensive
Active Research Program
49.1
27
NCI Comprehensive
Active Research Program
49.1
28
NCI Comprehensive
Active Research Program
49.1
29
NCI Comprehensive
Active Research Program
49.1
30
NCI Comprehensive
Active Research Program
49.1
31
NCI Comprehensive
Active Research Program
49.1
32
NCI Clinical
Active Research Program
49.1
33
NCI Comprehensive
Active Research Program
49.1
34
NCI Comprehensive
Active Research Program
49.1
35
NCI Comprehensive
Active Research Program
49.1
36
NCI Comprehensive
Active Research Program
49.1
37
NCI Clinical
Active Research Program
49.1
38
NCI Comprehensive
Active Research Program
49.1
39
Active Research Program
49.1
40
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
49.1
41
NCI Comprehensive
Active Research Program
49.1
42
Active Research Program
49.1
43
Active Research Program
49.1
44
NCI Comprehensive
Active Research Program
49.1
45
NCI Comprehensive
Active Research Program
49.1
46
NCI Clinical
Active Research Program
49.1
47
NCI Comprehensive
Active Research Program
49.1
48
NCI Comprehensive
Active Research Program
49.1
49
NCI Comprehensive
Active Research Program
49.1
50
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
49.1
51
NCI Clinical
Active Research Program
49.1
52
NCI Comprehensive
Active Research Program
49.1
53
Active Research Program
49.1
54
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
49.1
55
NCI Comprehensive
Active Research Program
49.1
5649.1
57
Active Research Program
49.1
58
Active Research Program
49.1
59
Active Research Program
49.1
60
Active Research Program
49.1
61
Active Research Program
49.1
62
Active Research Program
49.1
63
Active Research Program
49.1
6449.1
65
Active Research Program
49.1
66
Active Research Program
49.1
67
BC CancerVancouver, BC
Active Research Program
49.1
68
Active Research Program
49.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →